Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 5:48 pm Purchase | 13G | enGene Holdings Inc. ENGN | Venrock Healthcare Capital Partners III L.P. | 3,565,841 8.100% | 1,000,000 (+38.97%) | View |
| 2024-11-14 5:05 pm Purchase | 13G | enGene Holdings Inc. ENGN | Blue Owl Capital Holdings LP | 3,095,069 7.000% | 1,860,309 (+150.66%) | View |
| 2024-11-14 07:53 am Sale | 13G | enGene Holdings Inc. ENGN | Omega Fund VII L.P. | 1,397,859 3.100% | -208,393 (-12.97%) | View |
| 2024-11-12 09:30 am Purchase | 13G | enGene Holdings Inc. ENGN | Adage Capital Management L.P. | 2,329,768 5.270% | 2,329,768 (New Position) | View |
| 2024-11-01 4:04 pm Purchase | 13D | enGene Holdings Inc. ENGN | Forbion Growth Sponsor FEAC I B.V. | 9,201,434 17.200% | 561,797 (+6.50%) | View |
| 2024-10-18 4:15 pm Purchase | 13D | enGene Holdings Inc. ENGN | Forbion Growth Sponsor FEAC I B.V. | 8,639,637 18.500% | 470,633 (+5.76%) | View |
| 2024-02-26 4:15 pm Purchase | 13G | enGene Holdings Inc. ENGN | Venrock Healthcare Capital Partners III L.P. | 2,565,841 5.900% | 2,565,841 (New Position) | View |
| 2024-02-23 4:48 pm Purchase | 13G | enGene Holdings Inc. ENGN | Deep Track Capital LP | 2,250,000 5.210% | 2,250,000 (New Position) | View |
| 2024-02-23 1:32 pm Purchase | 13G | enGene Holdings Inc. ENGN | Foresite Capital Fund VI LP | 2,500,000 5.800% | 2,500,000 (New Position) | View |
| 2024-02-22 4:45 pm Unchanged | 13G | enGene Holdings Inc. ENGN | BIOTECHNOLOGY VALUE FUND L P | 3,196,439 7.200% | 0 (Unchanged) | View |
| 2024-02-21 4:15 pm Purchase | 13D | enGene Holdings Inc. ENGN | Lumira Capital Investment Management Inc. | 4,181,853 9.600% | 800,000 (+23.66%) | View |
| 2024-02-14 9:06 pm Purchase | 13G | enGene Holdings Inc. ENGN | Blue Owl Capital Holdings LP | 1,234,760 5.320% | 1,234,760 (New Position) | View |
| 2024-02-14 7:03 pm Purchase | 13G | enGene Holdings Inc. ENGN | Omega Fund VII L.P. | 1,606,252 6.800% | 1,606,252 (New Position) | View |
| 2024-02-14 07:21 am Sale | 13G | enGene Holdings Inc. ENGN | Forbion Capital Fund III Cooperatief U.A. | 3,369,275 14.200% | -536 (-0.02%) | View |
| 2023-11-13 4:45 pm Purchase | 13G | enGene Holdings Inc. ENGN | BIOTECHNOLOGY VALUE FUND L P | 3,196,439 13.200% | 3,196,439 (New Position) | View |
| 2023-11-13 4:01 pm Purchase | 13G | enGene Holdings Inc. ENGN | Forbion Capital Fund III Cooperatief U.A. | 3,369,811 14.200% | 3,369,811 (New Position) | View |
| 2023-11-13 3:34 pm Purchase | 13D | enGene Holdings Inc. ENGN | Forbion Growth Sponsor FEAC I B.V. | 8,169,004 31.900% | 8,169,004 (New Position) | View |
| 2023-11-07 6:07 pm Purchase | 13D | enGene Holdings Inc. ENGN | Lumira Capital Investment Management Inc. | 3,381,853 14.400% | 3,381,853 (New Position) | View |
| 2023-11-07 4:13 pm Purchase | 13G | enGene Holdings Inc. ENGN | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 3,088,682 13.100% | 3,088,682 (New Position) | View |